PRESS RELEASE published on 11/04/2024 at 20:05, 1 year 6 months ago Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital Poxel publie le nombre d'actions et de droits de vote composant son capital social conformément aux obligations réglementaires. Consultez le détail sur leur site web Capital Social Actions AMF Informations Réglementées Poxel
BRIEF published on 10/11/2024 at 07:35, 1 year 6 months ago Poxel Releases 2023 Universal Registration Document Corporate Governance Annual Financial Report CSR Report Poxel 2023 Registration Document
BRIEF published on 10/11/2024 at 07:35, 1 year 6 months ago Poxel publie son document d'enregistrement universel 2023 Gouvernance D'Entreprise Rapport Financier Annuel Poxel Rapport RSE Document D'enregistrement 2023
PRESS RELEASE published on 10/11/2024 at 07:30, 1 year 6 months ago Annual financial and audit reports / Terms of availability of the annual financial report Poxel announces availability of the 2023 Universal Registration Document including financial and governance reports, now filed with the AMF AMF Biopharmaceutical Company Financial Report Universal Registration Document Poxel
PRESS RELEASE published on 10/11/2024 at 07:30, 1 year 6 months ago Rapports financiers et d'audit annuels / Modalités de mise à disposition du rapport financier annuel Poxel annonce la mise à disposition de son Document d'Enregistrement Universel 2023 auprès de l'AMF pour l'exercice clos au 31 décembre 2023, incluant rapports financiers et sociaux AMF Maladies Métaboliques Document D'Enregistrement Universel Traitements Innovants Poxel
BRIEF published on 10/03/2024 at 18:35, 1 year 7 months ago Poxel annonce ses résultats financiers et stratégiques pour 2023 Résultats Financiers Biopharmaceutique TWYMEEG® Poxel OrbiMed
BRIEF published on 10/03/2024 at 18:35, 1 year 7 months ago Poxel announces its financial and strategic results for 2023 Financial Results Biopharmaceutical TWYMEEG® Poxel OrbiMed
PRESS RELEASE published on 10/03/2024 at 18:30, 1 year 7 months ago Informations privilégiées / Communiqué sur comptes, résultats Poxel publie ses résultats financiers pour l'année 2023 et dresse un bilan de ses activités. Accord avec OrbiMed, webinaires de présentation et perspectives de croissance Résultats Financiers Croissance Webinaires Poxel OrbiMed
BRIEF published on 09/30/2024 at 07:35, 1 year 7 months ago Poxel Secures $50M Non-Dilutive Financing from OrbiMed Non-dilutive Financing TWYMEEG® Poxel Royalty Monetization OrbiMed
BRIEF published on 09/30/2024 at 07:35, 1 year 7 months ago Poxel obtient un financement non dilutif de 50 millions de dollars auprès d'OrbiMed Financement Non Dilutif TWYMEEG® Poxel Monétisation Des Redevances OrbiMed
Published on 05/09/2026 at 01:30, 1 day 19 hours ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 1 day 21 hours ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/10/2026 at 16:05, 5 hours 11 minutes ago RingConn Gen 3 Smart Ring Opens for Pre-Order: Bringing Vascular Insights to Effortless Everyday Wear
Published on 05/10/2026 at 14:00, 7 hours 16 minutes ago MBC GROUP DELIVERS RESILIENT 1Q 2026 PERFORMANCE ANCHORED BY STRONG MBC SHAHID GROWTH
Published on 05/10/2026 at 11:45, 9 hours 31 minutes ago Hisense Kicks Off FIFA World Cup 2026™ Campaign, Bringing Fans Closer Through "Innovating a Brighter Life"
Published on 05/09/2026 at 19:05, 1 day 2 hours ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 2 days ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/07/2026 at 19:15, 3 days 2 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 3 days 2 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 3 days 2 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 3 days 2 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 3 days 2 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
